ATI RN
Lifespan Pharmacology Questions
Question 1 of 5
A 24-year-old female is prescribed erythromycin for gastroparesis. It is prescribed four times daily due to its short half-life. What is the rationale for such a frequent dosing?
Correct Answer: A
Rationale: The correct answer is A) Achieve the steady-state plasma concentration of the drug. In pharmacokinetics, steady-state concentration is reached when the rate of drug administration equals the rate of drug elimination. Erythromycin, being a drug with a short half-life, requires frequent dosing to maintain therapeutic levels in the body. By administering the drug four times daily, the goal is to achieve and maintain a steady-state plasma concentration, ensuring that the drug remains effective throughout the treatment period. Option B) Aid more complete distribution of the drug is incorrect because dosing frequency does not directly impact the distribution of the drug in the body. Distribution is more related to factors like tissue perfusion and drug affinity for specific tissues. Option C) Avoid the toxicity of the drug because of its low therapeutic index is incorrect because dosing frequency is not primarily determined based on the drug's therapeutic index. Toxicity is managed through appropriate dosing regimens and monitoring of drug levels. Option D) Ensure that the drug concentration remains constant over time is incorrect because maintaining a constant drug concentration is more related to dosing interval rather than dosing frequency. In an educational context, understanding the rationale behind dosing frequency is crucial for healthcare professionals to ensure optimal drug therapy outcomes. By grasping concepts such as steady-state concentration, practitioners can make informed decisions when prescribing medications to achieve desired therapeutic effects while minimizing the risk of toxicity.
Question 2 of 5
A 33-year-old woman was hospitalized after 1 week of increasing pain, tenderness, and cyanosis in her legs. She admitted to taking several medications to relieve a migraine headache. Physical examination revealed that no pulses could be palpated below the femoral vessels, and an aortogram showed a pronounced constriction of the vessels distal to the iliac arteries. The vasoconstriction disappeared after 3 hours of nitroprusside intravenous infusion. Which of the following drugs most likely caused the vessel constriction?
Correct Answer: C
Rationale: In this case, the correct answer is C) Ergotamine. Ergotamine is known to cause vasoconstriction by acting on vascular smooth muscle receptors. It is commonly used to treat migraines but can lead to severe vasoconstriction when taken in excess, as seen in this patient's presentation with decreased pulses and cyanosis in her legs. A) Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that does not typically cause vasoconstriction. It is more commonly associated with antiplatelet effects. B) Propranolol is a beta-blocker that works by blocking beta-adrenergic receptors and is not known to cause vasoconstriction. It is used to treat conditions like hypertension and cardiac arrhythmias. D) Acetaminophen is a pain reliever and fever reducer that does not have vasoconstrictive properties. It is generally well-tolerated and does not typically cause vascular complications. Educationally, understanding the pharmacological effects of different drugs is crucial for healthcare professionals to make informed decisions in patient care. This case highlights the importance of recognizing the potential adverse effects of medications, especially in the context of polypharmacy, to prevent serious complications like vascular constriction.
Question 3 of 5
A29-year-old woman suffering from allergic rhinitis started treatment with loratadine. The drug can completely counteract the histamine-induced release of which of the following endogenous compounds?
Correct Answer: D
Rationale: In this scenario, the correct answer is D) Nitric oxide. Loratadine, as an antihistamine, works by blocking the action of histamine on certain cells in the body. Histamine is a compound released during allergic reactions and triggers various responses. One of these responses is the release of nitric oxide, which plays a role in inflammation and vasodilation. Option A) Pepsin is a digestive enzyme produced in the stomach and is not directly affected by antihistamines like loratadine. Option B) Gastric acid production is not directly inhibited by antihistamines like loratadine. Histamine does play a role in stimulating gastric acid secretion, but loratadine primarily targets histamine receptors involved in allergic responses. Option C) Cyclic adenosine monophosphate (cAMP) is a signaling molecule that can be influenced by histamine, but loratadine's primary mechanism of action is through histamine receptors rather than cAMP pathways. Educationally, understanding the interactions between drugs and endogenous compounds like histamine and nitric oxide is crucial in pharmacology. It highlights the specific targets and mechanisms of action of different medications, aiding in the selection of appropriate treatments for various conditions. This knowledge is essential for healthcare professionals to provide safe and effective care to patients.
Question 4 of 5
A 21-year-old woman suffering from seasonal allergic conjunctivitis started a treatment with eye drops of azelastine, a second-generation histamine H1 antagonist. Second-generation H1 antagonists are used locally in the conjunctiva instead of first-generation H1 antagonists to provide which of the following therapeutic advantages?
Correct Answer: A
Rationale: The correct answer is A) Negligible effects on pupil size and accommodation. Second-generation H1 antagonists like azelastine are preferred for local use in the conjunctiva over first-generation H1 antagonists due to their selective action on histamine receptors in the target tissue, which leads to reduced systemic side effects. Option B) Negligible penetration into the central nervous system is incorrect because second-generation H1 antagonists still have the potential to enter the systemic circulation and reach the central nervous system, albeit in lower amounts compared to first-generation drugs. Option C) Higher dilating activity on conjunctival vessels is incorrect as second-generation H1 antagonists are chosen for their lower affinity for blood vessels in the conjunctiva, leading to reduced risk of vascular dilation and subsequent redness. Option D) Higher blocking activity on lacrimal gland secretion is incorrect because second-generation H1 antagonists are not selected for their increased blocking activity on lacrimal gland secretion but rather for their reduced impact on pupil size and accommodation. In an educational context, understanding the differences between first and second-generation H1 antagonists is crucial for healthcare professionals to make informed decisions when prescribing medications for conditions like allergic conjunctivitis. Second-generation drugs offer a more targeted approach with fewer systemic side effects, making them a preferred choice for local treatment in sensitive areas like the eye.
Question 5 of 5
What is implied by 'active transport'?
Correct Answer: D
Rationale: Active transport refers to the movement of substances across a cell membrane against their concentration gradient, requiring energy expenditure in the form of ATP. This process allows the cell to accumulate substances against their concentration gradients to maintain cellular functions. Option A is incorrect because diffusion is a passive process, not an active transport mechanism that requires energy. Option B is incorrect because active transport does involve energy consumption. Option C describes endocytosis, a process where the cell engulfs material by wrapping cell membrane around it to form a vesicle, which is not the same as active transport. Understanding active transport is crucial in pharmacology as it explains how certain drugs can be transported into cells even when there is a higher concentration of the drug outside the cell. This knowledge is vital in designing drugs that can effectively target specific cells or organelles within the body. It also helps in understanding drug resistance mechanisms where cells may actively pump out drugs using active transport mechanisms.